Follow us on

News Summary: NJ drugmaker to pay $45M in fines

Source : AP
Last Updated: Wed, Mar 06, 2013 05:00 hrs

: Executives of drugmaker Par Pharmaceutical Cos. pleaded guilty Tuesday to criminal misbranding, for years of improperly marketing its weight-gain drug for frail nursing home and hospice patients vulnerable to its potentially deadly side effects. The drug, Megace ES, is approved only for AIDS patients.

FINANCIAL PENALTY: The Woodcliff Lake, N.J., company will pay a total of $45 million to resolve criminal and civil charges in the case. It also agreed to increased government monitoring.

BACK STORY: The Justice Department started investigating after four whistleblowers went to attorneys with allegations about misconduct by Par's sales force for the drug.

blog comments powered by Disqus
most popular on facebook
talking point on sify finance